瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01501 瑛泰医疗

未开盘 07-02 16:08:21

31.500

+0.900

+2.94%

最高32.380	最低31.000	成交量13.38万
今开31.000	昨收30.600	日振幅4.51%
总市值66.47亿	流通市值66.47亿	总股本2.11亿
成交额426.53万	换手率0.06%	流通股本2.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01501","market":"HK","secType":"STK","nameCN":"瑛泰医疗","latestPrice":31.5,"timestamp":1782979701004,"preClose":30.6,"halted":0,"volume":133800,"delay":0,"changeRate":0.029411764705882304,"floatShares":211000000,"shares":211000000,"eps":1.26,"marketStatus":"未开盘","change":0.9,"latestTime":"07-02 16:08:21","open":31,"high":32.38,"low":31,"amount":4265300,"amplitude":0.045098,"askPrice":31.98,"askSize":1000,"bidPrice":31.3,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.147,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":0,"adr":0,"listingDate":1573142400000,"exchange":"SEHK","adjPreClose":30.6,"dividendRate":0.008257,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":0.956808,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603987","market":"SH","secType":"STK","nameCN":"康德莱","latestPrice":7.16,"timestamp":1782975600000,"preClose":7.13,"halted":0,"volume":4400400,"delay":0,"premium":"+280.79"}},"requestUrl":"/m/hq/s/01501","defaultTab":"news","newsList":[{"id":"1143242081","title":"瑛泰医疗6月股份变动月报：H股增至2.11亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143242081","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143242081?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:11","pubTimestamp":1782983498,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年7月2日披露截至2026年6月30日止的股份变动月报，公告显示公司本月完成内资股转H股操作，H股数量大幅上升。本次报告期内，瑛泰医疗已发行H股由上月底的139,413,392股增加至211,200,000股，增加数量为71,786,608股；与此同时，内资股从71,786,608股降至0股，显示全部内资股均于2026年6月3日转换为H股。本次月报由公司主席兼执行董事梁栋科签署。公司强调将持续满足香港联交所对于股份发行、买卖和信息披露的合规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647887303","title":"瑛泰医疗(01501.HK)根据H股奖励信托计划授出3.34万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2647887303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647887303?lang=zh_cn&edition=full","pubTime":"2026-06-29 23:15","pubTimestamp":1782746123,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647832004","title":"康德莱：瑛泰医疗的价值放大，有益于所有持有其股份的投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2647832004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647832004?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:54","pubTimestamp":1782726847,"startTime":"0","endTime":"0","summary":"证券之星消息，康德莱06月29日在投资者关系平台上答复投资者关心的问题。你公司持有瑛泰医疗股份。瑛泰医疗的价值放大，有益于所有持有其股份的投资者。关于中报业绩情况，公司将严格按照交易所要求履行信息披露义务，请您关注公司后续公告。股价波动受多重因素影响，公司经营正常有序。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603987","01501","BK0251","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801312","title":"瑛泰医疗(01501)拟斥资1000万美元进一步收购德晋医疗约0.79%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801312","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646801312?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:54","pubTimestamp":1782399279,"startTime":"0","endTime":"0","summary":"据悉，目标公司持有德晋医疗100%股权。其中，DragonFly经导管二尖瓣夹系统为国家药监局批准的首款国产经导管二尖瓣产品。于首次收购事项及第二次收购事项均完成后，公司将合共持有目标公司已发行股本总额约23.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114269978","title":"瑛泰医疗（01501）再投1,000万美元增持Valgen 0.79%股权，持股升至23.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114269978","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114269978?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:52","pubTimestamp":1782399143,"startTime":"0","endTime":"0","summary":"6月25日，上海瑛泰医疗器械股份有限公司公告，与Qiming Venture Partners VI, L.P.及Qiming Managing Directors Fund VI, L.P.签订进一步股份转让协议，以1,000万美元收购Valgen Holding Corporation 119,545股B轮优先股，约占其已发行股本的0.79%。交易完成后，瑛泰医疗在Valgen的持股比例将由23.18%提升至23.97%。财务数据显示，Valgen 2025年度收入2.06亿元人民币，净利润4,957.32万元；2024年度收入1.01亿元人民币，净亏损4,035.19万元。瑛泰医疗表示，逐步增持Valgen有助于完善结构性心脏病产品管线，提升在心血管介入领域的整体竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642266553","title":"瑛泰医疗(01501)：上海证监局已受理公司就建议发行A股进行上市前辅导的备案登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2642266553","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642266553?lang=zh_cn&edition=full","pubTime":"2026-06-12 16:48","pubTimestamp":1781254097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布公告，公司建议于中国证券交易所发行A股。董事会进一步宣布：公司已委任国泰海通证券股份有限公司作为公司建议发行A股有关工作的上市前辅导机构并与其签署辅导协议;及公司已获通知，中国证券监督管理委员会上海监管局已受理公司就建议发行A股进行上市前辅导的备案登记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","IPOS","399300","01501","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640359138","title":"瑛泰医疗(01501)存仓市值总计23.76亿港元 其中股东向中国证券登记结算香港存入7178.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640359138","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640359138?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:18","pubTimestamp":1780532324,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月3日，瑛泰医疗(01501)出现仓位异动，存仓市值总计23.76亿港元，占比33.99%。该公司股东将股票存入中国证券登记结算香港7178.66万股，持股比例增加21.11%。瑛泰医疗公告，7178.66万股内资股转换为H股已于2026年6月3日完成，而7178.66万股经转换H股将于2026年6月4日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后，方可进行经转换H股交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","161027","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185129764","title":"瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1185129764","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185129764?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:58","pubTimestamp":1780477107,"startTime":"0","endTime":"0","summary":"瑛泰医疗（01501）于2026年6月3日发布公告，宣布将12名参与股东所持有的71,786,608股内资股转换为H股。该部分转股占转换前公司已发行股本的33.99%。\n公司在本次转换并上市后已发行股本总数维持211,200,000股H股，此前境内上市的内资股则由71,786,608股降至0股。公司表示有关注册转换与上市所需的法律规定及香港联交所相关上市规则，并确认所有程序均已获得董事会正式授权并遵守适用的法律及监管规定。\n本次公告由公司董事长兼执行董事梁栋科签署。公司称，此次转股完成后，其已发行股份的整体架构调整已顺利实施。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗完成71,786,608股内资股转换至H股 已发行股本变动","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972220","title":"瑛泰医疗(01501)：完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972220","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972220?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:31","pubTimestamp":1780475480,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布公告，7178.66万股内资股转换为H股已于2026年6月3日完成，而7178.66万股经转换H股将于2026年6月4日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后，方可进行经转换H股交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗(01501)：完成H股全流通","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179736144","title":"瑛泰医疗5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1179736144","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179736144?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:56","pubTimestamp":1780304185,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司（01501）于2026年6月1日发布2026年5月股份变动月报表，披露了公司截至2026年5月31日的股本及股份变动情况。\n公告显示，报告期内公司已发行股本结构保持不变，未发生新增发行、股份购回、注销或库藏股变动。截至2026年5月末，公司已发行股本总额为人民币211,200,000元，其中国际上市的H股139,413,392股（面值人民币1元），内资股71,786,608股（面值人民币1元）。\n公司同时确认，当前已满足香港联交所主板上市规则对于公众持股量的具体要求。本次公告由公司主席兼执行董事梁栋科签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698506","title":"瑛泰医疗：6月30日将派发股息0.26港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698506","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638698506?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:44","pubTimestamp":1779968640,"startTime":"0","endTime":"0","summary":"南财智讯5月28日电，瑛泰医疗（01501.HK）公告，公司于2026年5月28日举行的股东周年大会上，批准截至2025年12月31日止年度的末期股息为每股人民币0.23元（相当于每股0.26港元）。为确定有权收取股息的股东名单，公司将于2026年6月5日至6月10日暂停办理股份过户登记手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752947984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","EWH","01501","BK4588","VIG","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136635404","title":"瑛泰医疗宣派末期股息每股0.23元，拟于6月30日派付","url":"https://stock-news.laohu8.com/highlight/detail?id=1136635404","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136635404?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:41","pubTimestamp":1779968487,"startTime":"0","endTime":"0","summary":"瑛泰医疗公告，公司于2026年5月28日举行的股东周年大会上，正式通过截至2025年12月31日止年度的利润分配方案，批准派发末期股息每股人民币0.23元（含税），折合每股0.26港元。此次股息以人民币计值及宣派。拟派末期股息预计于2026年6月30日或前后向名列当日股东名册的股东派付。港元兑换汇率采用董事会通过宣派股息之日前五个工作日中国人民银行公布的港元兑人民币汇率平均值，即1.135港元兑1.00元人民币，据此每股H股末期股息为0.26港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗宣派末期股息每股0.23元，拟于6月30日派付","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136786546","title":"瑛泰医疗终止认购堃博医疗新股　原拟2.83亿港元交易一致撤销","url":"https://stock-news.laohu8.com/highlight/detail?id=1136786546","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136786546?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:52","pubTimestamp":1779792722,"startTime":"0","endTime":"0","summary":"瑛泰医疗与堃博医疗控股有限公司于2026年5月26日签署终止协议，双方一致解除2025年10月10日订立的认购协议，并取消原计划进行的全部交易安排。根据2025年认购协议，瑛泰医疗曾计划以每股3.11港元认购堃博医疗91,093,613股新股份，总对价约2.83亿港元。公告指出，截至终止协议签署日期，瑛泰医疗尚未就该认购向堃博医疗支付任何款项。瑛泰医疗董事会表示，终止该认购不会对集团的财务状况及营运构成重大不利影响，且符合公司及股东整体利益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638333516","title":"瑛泰医疗(01501)终止认购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2638333516","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638333516?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:49","pubTimestamp":1779792550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布公告，内容有关根据本公司与堃博医疗控股有限公司(堃博医疗，股份代号：2216)所订立日期为2025年10月10日的认购协议认购9109.36万股堃博医疗新股份，认购价为每股认购股份3.11港元，总代价为2.83亿港元。于2026年5月26日，本公司与堃博医疗订立终止协议，据此，双方一致同意终止认购协议及其项下拟进行的交易。根据终止协议，认购协议项下的所有义务及责任悉数且不可撤销地解除(各项认购协议项下的保密责任除外)，双方就此概无任何相互申索的权利(各项认购协议项下的保密责任除外)。于本公告日期，本公司尚未根据认购协议向堃博医疗支付任何代价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143071115","title":"瑛泰医疗终止认购堃博医疗新股协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143071115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143071115?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:47","pubTimestamp":1779792466,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司宣布，已终止此前与堃博医疗就认购其新发行股份达成的协议。该决定意味着，相关股份认购计划将不再推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635278289","title":"瑛泰医疗(01501)：联交所就实施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278289","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635278289?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:23","pubTimestamp":1778674980,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗(01501)发布公告，本公司已向联交所上市委员会申请批准根据转换12名股东持有的7178.66万股内资股(转换)而拟转换的7178.66万股H股(经转换H股)上市及买卖经转换H股(上市批准)。本公司欣然宣布，联交所已于2026年5月13日授出上市批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634248670","title":"瑛泰医疗(01501)拟斥资约1.08亿美元收购德晋医疗23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634248670","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634248670?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:41","pubTimestamp":1778596903,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑛泰医疗 公布，于2026年5月11日及2026年5月12日，公司就以总对价约1.08亿美元收购Valgen Holding Corporation23.18%股权，分别与卖方订立股份转让协议。据悉，目标公司持有德晋医疗100%股权。德晋医疗主要从事房室瓣疾病方面介入治疗技术及产品的研发、生产及销售。德晋医疗为目标集团在中国的主要经营实体。其中，DragonFly经导管二尖瓣夹系统为国家药监局批准的首款国产经导管二尖瓣产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198395251","title":"瑛泰医疗斥资1.077亿美元，收购Valgen Holding Corporation 23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1198395251","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198395251?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:39","pubTimestamp":1778596752,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司达成一项交易，以107,758,127美元的价格，收购Valgen Holding Corporation 23.18%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152812105","title":"瑛泰医疗拟收购Valgen Holding Corporation 23.18%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1152812105","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152812105?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:39","pubTimestamp":1778596750,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司宣布，将收购Valgen Holding Corporation的23.18%股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288870","title":"瑛泰医疗(01501)获中国证监会发出H股全流通申请备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288870","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288870?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:47","pubTimestamp":1778496427,"startTime":"0","endTime":"0","summary":"瑛泰医疗(01501)公布，公司已就将公司12名股东持有的合共71,786,608股内资股转换为H股，代表该等12名股东向中国证监会提出申请。董事会宣布，于2026年5月9日，公司已收到日期为2026年4月27日且由中国证监会就H股全流通发出的上海瑛泰医疗器械股份有限公司境内未上市股份全流通备案通知书。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kdlchina.com","stockEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.0695},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.288},{"period":"ytd","weight":0.059}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.1146},{"period":"3month","weight":-0.0821},{"period":"6month","weight":-0.1247},{"period":"1year","weight":-0.0482},{"period":"ytd","weight":-0.1005}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海瑛泰医疗器械股份有限公司（原名：上海康德莱医疗器械股份有限公司）是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发，例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.045707},{"month":2,"riseRate":0.285714,"avgChangeRate":0.009958},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.013734},{"month":4,"riseRate":0.714286,"avgChangeRate":0.03758},{"month":5,"riseRate":0.285714,"avgChangeRate":0.072512},{"month":6,"riseRate":0.428571,"avgChangeRate":0.055661},{"month":7,"riseRate":0.714286,"avgChangeRate":0.014359},{"month":8,"riseRate":0.666667,"avgChangeRate":0.02216},{"month":9,"riseRate":0.5,"avgChangeRate":-0.072581},{"month":10,"riseRate":0.5,"avgChangeRate":0.064903},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.077012},{"month":12,"riseRate":0.714286,"avgChangeRate":0.030589}],"exchange":"SEHK","name":"瑛泰医疗","nameEN":"INT MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑛泰医疗,01501,瑛泰医疗股票,瑛泰医疗股票老虎,瑛泰医疗股票老虎国际,瑛泰医疗行情,瑛泰医疗股票行情,瑛泰医疗股价,瑛泰医疗股市,瑛泰医疗股票价格,瑛泰医疗股票交易,瑛泰医疗股票购买,瑛泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}